Can recurring breast cancer be cured?

Whether breast cancer recurrence can be cured cannot be generalized. It is related to the site of recurrence and metastasis. The specific situations are as follows: 1. Local recurrence: common chest wall recurrence and regional lymph node invasion, such as axillary lymph nodes and ipsilateral supraclavicular lymph nodes. After effective treatment, there is a possibility of cure; 2. Distant metastasis: The cure rate is low and it is basically an incurable disease. The purpose of treatment is to improve the patient's quality of life and prolong the patient's survival. However, in clinical practice, about 3%-5% of patients are still completely cured despite distant metastasis.

How long can you live if breast cancer recurs?

There are individual differences in the survival of patients with recurrent and metastatic breast cancer, which is related to their hormone receptors, typing, staging, treatment methods, and psychological state. For example, a clinical case of a female patient with liver metastasis had liver metastasis in 2/3 of the liver and abnormal liver function. The expected survival period was no more than three months. After subsequent continuous standard treatment, she has now survived for eight years. The entire treatment benefited from the patient's good mentality, the understanding and support of her family, and the effective treatment plan. It is recommended that patients with recurrent and metastatic breast cancer do their best to cooperate with doctors in active treatment.

How long can you live with early breast cancer?

Compared with other solid tumors, breast cancer has a relatively good treatment effect. Active treatment of early breast cancer can achieve good treatment results, with a five-year survival rate of 80%-90%. With the progress of molecular targeted therapy, the treatment of breast cancer pays more attention to molecular typing. According to ERPR, HER2 gene and Ki-67 indicators, breast cancer is divided into four different molecular types, namely Luminal A, Luminal B, HER2 overexpression and triple-negative breast cancer. The prognosis of Luminal type is relatively good, while the prognosis of HER2 overexpression and triple-negative breast cancer is relatively poor. Early diagnosis and early treatment are recommended.